Hall Jesse Wayne 4
4 · Aclaris Therapeutics, Inc. · Filed Feb 6, 2026
Research Summary
AI-generated summary of this filing
Aclaris (ACRS) CMO Jesse Hall Receives RSU Awards
What Happened
Jesse Wayne Hall, Chief Medical Officer of Aclaris Therapeutics (ACRS), received two restricted stock unit (RSU) awards on February 2, 2026 totaling 441,400 RSUs (98,100 + 343,300). Each RSU represents a contingent right to one share; the awards were granted at $0.00 (no cash paid) and are recorded as derivative acquisitions in the Form 4.
Key Details
- Transaction date: February 2, 2026; Form 4 filed February 6, 2026.
- Grant details: 98,100 RSUs and 343,300 RSUs, grant price $0.00; total RSUs = 441,400.
- Value: No cash was paid at grant; economic value depends on future stock price when RSUs settle.
- Vesting: The shares underlying these RSUs vest in four equal installments on the 1st, 2nd, 3rd and 4th anniversaries of February 2, 2026, subject to continuous service (see footnote F2).
- Footnotes: F1 — each RSU converts to one common share upon settlement; F3 describes a 25%/four-year vesting arrangement for options (no option exercise reported in this filing).
- Shares owned after transaction: Not specified in the provided filing excerpt.
- Timeliness: Filed Feb 6, 2026, four days after the grant (Form 4s are normally due within 2 business days), so this filing appears later than the typical 2-business-day deadline.
Context
RSU grants are a form of compensation and do not represent an open-market purchase (so they’re not a direct bullish purchase signal). They convert to actual shares only as they vest and subject to continued employment; tax withholding or other mechanics may apply at settlement. This filing reports the award/grant (derivative grant) rather than a sale, purchase, or option exercise.
Insider Transaction Report
- Award
Restricted Stock Units
[F1][F2]2026-02-02+98,100→ 98,100 total→ Common Stock (98,100 underlying) - Award
Employee Stock Option (Right to Buy)
[F3]2026-02-02+343,300→ 343,300 totalExercise: $3.61Exp: 2036-02-01→ Common Stock (343,300 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock of the issuer.
- [F2]The shares underlying these restricted stock units vest in four equal installments on the first, second, third and fourth anniversaries of February 2, 2026, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.
- [F3]Exercisable with respect to 25% of the shares subject to the option vesting in four equal installments on the first, second, third and fourth anniversaries of February 2, 2026, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of each such date.